
2026-04-08
Unyango lwakwangoko lomhlaza wemiphunga ngo-2026 lubhekisa kungenelelo oluphambili lwezonyango olusetyenziselwa ukufumanisa nokulawula umhlaza wemiphunga kumanqanaba awo okuqala, ukuphucula kakhulu amazinga okusinda. Iindlela zangoku e-China kunye nehlabathi jikelele zidibanisa ubukrelekrele bokwenziwa (AI) ukuze kubonwe kwangethuba, iindlela ezichanekileyo zotyando, unyango olujoliswe kuyo, kunye ne-immunotherapy. Izigulane zifuna unyango lomhlaza wemiphunga kwangoko ngoku inokufikelela kwiinkqubo zovavanyo ezingabizi kakhulu, ezinje nge-AI-yomelezelw i-CT scans ezifumaneka kwizibhedlele ezikhulu zaseTshayina malunga ne-25 yeedola, ecaleni konyango lwenkqubo olusikelelwe elwenza umntu abe nokhathalelo olusekwe kwiiprofayili zofuzo.
Umhlaza wamaphaphu uhlala ungoyena nobangela uphambili wokusweleka okunxulumene nomhlaza kwihlabathi liphela, kodwa imeko ye unyango lomhlaza wemiphunga kwangoko iye yatshintsha kakhulu ngo-2026. Ukutshintshwa kwindlela yokulinganisa yonke into ukuya kwiyeza elichanekileyo liye lachaza iziphumo zesigulane. Ukufunyaniswa kwangethuba ngoku kulilitye lembombo kunyango oluyimpumelelo, kunye nobuchwepheshe obutsha obuvumela oogqirha ukuba bachonge amathumba phambi kokuba kuvele iimpawu.
Inkcazo yomhlaza wemiphunga wenqanaba lokuqala ngokuqhelekileyo ibandakanya iSigaba soku-I kunye neSigaba sesi-II somhlaza wemiphunga engeyiyo encinci (NSCLC), apho ithumba lenziwe lasekhaya kwaye alizange lisasazeke kumalungu akude. Ngo-2026, ugxininiso alukho nje ekususeni ithumba kodwa ekuthinteleni ukuphindaphinda ngonyango lwe-adjuvant olulungiselelwe ukuguqulwa kofuzo oluthile lwesigulana.
Uphuculo lwakutsha nje lwenze ukuba kube nokwenzeka ukunyanga umhlaza wemiphunga njengemeko engapheliyo kunokuxilongwa ngokubulalayo kwizigulana ezininzi. Ukudityaniswa kwe Uxilongo oluqhutywa yi-AI kwaye utyando olungenabungozi kancinci iye yanciphisa amaxesha okubuyisela kwaye yaphucula umgangatho wobomi emva konyango.
Enye yezona zinto zibalulekileyo ngo-2026 kukwamkelwa ngokubanzi kweemodeli ze-AI kwiradiology. Ezi nkqubo zihlalutya idosi ephantsi ye-computed tomography (LDCT) iskeni ngokuchaneka okungazange kubonwe ngaphambili, ukuchonga amaqhuqhuva afihlakeleyo anokuthi awaphose amehlo abantu.
E-China, izibhedlele ezifana neSibhedlele esiNxibeleniswa neYunivesithi yaseNingbo ziye zasebenzisa iimodeli ze-AI eziphuhliswe ngamaziko ophando afana ne-DAMO Academy. Ezi modeli ziye zahlalutya amakhulu amawaka e-CT scans, ebonisa ngempumelelo umhlaza wepancreatic kunye nemiphunga kwizigulane ezibonise iimpawu ezinganxulumananga.
Le teknoloji ibaluleke kakhulu kumhlaza wemiphunga, apho izinga lokusinda leminyaka emihlanu litsiba ukusuka ngaphantsi kwe-10% kumanqanaba okugqibela ukuya ngaphezulu kwama-70% xa lifunyenwe kwangoko. Ukukwazi ukwenza oku kuhlolwa ngeqhezu leendleko zemveli-ngamanye amaxesha ephantsi njenge-25 yeedola kwiinkqubo zokulinga-kuvuse umdla wehlabathi ekuthatheni iimodeli ezifanayo.
I-China iye yavela njenge-hub yehlabathi kukhathalelo olutsha lomhlaza wemiphunga, ukudibanisa umthamo omkhulu wezigulana kunye nokwamkelwa okukhawulezayo kwetekhnoloji. Amaziko amaninzi akhokelayo unyango lomhlaza wemiphunga kwangoko, ibonelela ngezixhobo ezikumgangatho wehlabathi kunye nophando olungoovulindlela.
Ifumaneka eShanghai, esi sibhedlele siphambili kuphando lomhlaza wemiphunga kunye nonyango. Kutshanje isungule i-"2026 CACA Lung Cancer Full-Domain Popular Science Action," ejonge ukuzisa uthintelo, uvavanyo, ukuxilongwa, unyango, kunye neengqikelelo zokubuyisela kwisimo sangaphambili eluntwini.
Isebe le-oncology yesibhedlele, elikhokelwa ziingcali ezidumileyo ezifana noNjingalwazi uZhou Caicun, ugxininisa ukuba umhlaza wemiphunga awusesona sifo esinye kodwa iqela lezifo ezichazwe ngabaqhubi abahlukeneyo. Le filosofi iqhuba iiprothokholi zabo zonyango ezenzelwe wena.
Njengenkulumbuso yesibhedlele esiyingcali yomhlaza, iFudan University Shanghai Cancer Centre iphambili kwinguqulelo yotyando kunye nolingo lwezonyango. Eli ziko lidlala indima ephambili ekuhlaziyeni izikhokelo zesizwe, kuquka “iNcwadi eNcinci eBomvu” yolawulo lomhlaza wamabele nemiphunga.
Iziko liyaziwa ngokubambelela ngokuqinileyo kubungqina obusekwe kubungqina ngelixa lidibanisa ngokukhawuleza ii-arhente ezintsha zonyango kuqheliselo lwezonyango. Amaqela abo asebenza ngeendlela ezininzi aqinisekisa ukuba isigulana ngasinye sifumana uvandlakanyo olubanzi olubandakanya oogqirha botyando, ii-oncologists zonyango, kunye neengcali zemitha.
Ukufumana ingqalelo yamazwe ngamazwe, esi sibhedlele sibonisa amandla e-AI ekunyamekeleni okuqhelekileyo. Isebenza njengendawo yokulinga imodeli ye-DAMO PANDA AI, ebonisa indlela itekhnoloji enokuthi ivale isithuba phakathi kokhathalelo olukhethekileyo kunye nokuhlolwa kwezempilo ngokubanzi.
Izigulana apha ziyaxhamla ekuhambeni komsebenzi okungenamthungo apho izilumkiso ze-AI zibangela uphononongo olukhawulezileyo lweengcali, ziqinisekisa ukuba akukho zimpawu zokuqala zobubi ezingahoywayo. Le modeli iyaphindwa kwizibhedlele ezininzi zoluntu kulo mmandla.
Umba wemali wokhathalelo lwempilo yinkxalabo ebalulekileyo kwizigulana kwihlabathi jikelele. Ngo-2026, ulwakhiwo lweendleko ze unyango lomhlaza wemiphunga kwangoko iyahluka kakhulu ngokuxhomekeke kwilizwe, iteknoloji esetyenziswayo, kunye nenqanaba lobhaqo.
Iindlela zokuhlola eziqhelekileyo kumazwe aseNtshona zinokubiza kakhulu, ngokufuthi zixabisa amakhulu eedola kwi-CT scan enye. Nangona kunjalo, ukuhlanganiswa kwe-AI e-China kuye kwaphazamisa le modeli.
Iinkqubo ezilingwayo ezisebenzisa i-AI-ephuculweyo ye-flat-scan CTs zicuthe iindleko zokujonga ukuya kuqikelelo $25 USD. Oku kuncitshiswa kakhulu kufezwa ngoku:
Oku kufikeleleka kwenza ukuba uvavanyo oluthe gqolo lwenzeke kuluntu olubanzi, olunokuthi lutshintshe igophe lokuxilonga liye kumanqanaba angaphambili apho unyango lungangeneleli kwaye lungabizi kakhulu.
Ngelixa ukuhlolwa kuye kwafikeleleka ngakumbi, iindleko zonyango oluqinisekileyo zixhomekeke kwindlela ekhethiweyo. Uqhaqho loqhaqho, umgangatho wegolide womhlaza wemiphunga okwinqanaba lokuqala, kubandakanya ukuhlala esibhedlele, i-anesthesia, kunye neentlawulo zotyando.
E-China, iindleko ezipheleleyo zokuhlinzwa okuncinci kwevidiyo ye-thoracoscopic (i-VATS) inokuvela kwi-$ 3,000 ukuya kwi-$ 8,000, iphantsi kakhulu kuneenkqubo ezifaniswayo e-US okanye eYurophu. Oku kubandakanya iitshekhi zangaphambi kotyando kunye nokhathalelo lwasemva kotyando.
Kwizigulane ezifuna unyango lwe-adjuvant, iindleko ziyahluka ngokusekelwe kumachiza asetyenzisiweyo. I-chemotherapy yesiNtu ayibizi kakhulu, ngelixa iindlela ezintsha zonyango ezijoliswe kuzo kunye ne-immunotherapies zinokubiza kakhulu. Nangona kunjalo, izikim ze-inshorensi yesizwe kunye nemigaqo-nkqubo yokuthengwa kwempahla eninzi e-China zithobe kakhulu iindleko eziphuma epokothweni zala machiza ahambele phambili.
| Icandelo | Iindleko eziqikelelweyo eTshayina (USD) | Iindleko eziqikelelweyo e-USA (USD) | Amanqaku |
|---|---|---|---|
| Uvavanyo lwe-LDCT oluphuculweyo lwe-AI | $25 - $60 | $300 - $800 | I-China iphakamisa i-AI ekusebenzeni kakuhle kovavanyo. |
| Uqhaqho lwe-VATS (Inqanaba lokuqala) | $3,000 - $8,000 | I-$ 20,000 - $ 50,000 + | Kubandakanya ukuhlala esibhedlele kunye nokhathalelo olusisiseko. |
| Unyango olujolisiweyo (Nyanga nganye) | $500 - $2,000 | $10,000 - $15,000 | Amaxabiso ayohluka ngokwamayeza athile kunye ne-inshorensi. |
| Immunotherapy (Ngomjikelo ngamnye) | $1,000 - $3,000 | $12,000 - $20,000 | Ukuthengwa kwezinto ezininzi kunciphisa iindleko eTshayina. |
Le theyibhile igxininisa umahluko omkhulu kuqoqosho lwezempilo. Ngelixa umgangatho wokhathalelo kwizibhedlele eziphezulu zaseTshayina zikhuphisana nezo zaseNtshona, inzuzo yeendleko yenza unyango lomhlaza wemiphunga kwangoko ifikeleleke ngakumbi kummi ophakathi.
Izixhobo zokulwa nomhlaza wemiphunga zande kakhulu. Ngo-2026, unyango alusekho kuphela kuqhaqho kunye ne-chemotherapy. Uluhlu lwamayeza achanekileyo lunika ithemba nakwiimeko ezinzima.
Ukuqonda ukwakheka kwemfuza yethumba ngoku kuyinxalenye eqhelekileyo yenkqubo yokuxilonga. Abaqhubi abafana ne-EGFR, ALK, ROS1, kunye ne-KRAS bayalela ukuba kukhethwe unyango.
Isizukulwana sesithathu i-EGFR tyrosine kinase inhibitors (TKIs) ngumgangatho wokunyamekela kwe-EGFR-mutated NSCLC. Nangona kunjalo, ukuxhathisa ngokuqinisekileyo kuyakhula. Impumelelo yamva nje ijongana ngqo nalo mngeni.
Ii-ADCs zibonisa utshintsho lweparadigm kwi-oncology. Ezi "bhombu zikrelekrele" zihambisa ichemotherapy enamandla ngokuthe ngqo kwiiseli zomhlaza, zigcina izicubu ezisempilweni. Ngo-2026, ii-ADCs ezijolise kwi-TROP2 zibonise ukusebenza okumangalisayo kwizigulane eziqhubele phambili kwi-EGFR-TKIs.
Ulingo lwezonyango, olufana nophononongo lwe-OptiTROP-Lung04 olukhokelwa ngabaphandi baseTshayina, lubonise ukuba i-TROP2-directed ADCs inokwandisa kakhulu ukusinda okungenankqubela-phambili xa kuthelekiswa nechemotherapy eqhelekileyo. Oku kuseke umgangatho omtsha wokhathalelo lwamatyala axhathisayo.
I-Immune checkpoint inhibitors (ICIs) iyaqhubeka ingundoqo, kodwa i-wave elandelayo ibandakanya ii-antibodies ze-bispecific ezibandakanya amajoni omzimba ngokufanelekileyo. La machiza angajolisa kwii-antigens ezimbini ezahlukeneyo ngaxeshanye, ephucula impendulo yokuzikhusela kwi-tumor.
Kwizigulane zesigaba sokuqala, i-neoadjuvant immunotherapy (enikwe phambi kotyando) ifumana i-traction. Uphononongo lucebisa ukuba le ndlela inokucutha amathumba, yenze utyando lube lula kwaye icuthe umngcipheko wokuphinda.
Nangona ubukhulu becala bukwindawo yovavanyo lweklinikhi, unyango lweeseli olufana ne-CAR-T luphononongwa ngamathumba aqinileyo aquka umhlaza wemiphunga. Ukongeza, izitofu zokugonya zomhlaza ezilungiselelwe umntu okhethekileyo neoantigens zibonisa isithembiso sokuthintela ukuphinda emva koqhaqho.
Ukuhamba ngenkqubo yokhathalelo lwempilo kunokuba nzima. Kwabo bafuna unyango lomhlaza wemiphunga kwangoko, ngakumbi kwimimandla enobuchule obuphambili njengeChina, ukulandela indlela eyakhiweyo iqinisekisa iziphumo ezilungileyo.
Le ndlela icwangcisiweyo yongeza amathuba onyango kwaye inciphisa ungenelelo olungeyomfuneko.
Ukukhetha indlela efanelekileyo yonyango kufuna ukuqonda okulungileyo kunye nokubi kwiinketho ezikhoyo. Apha ngezantsi kuthelekiso lweendlela eziphambili ezisetyenziswe ngo-2026 kumhlaza wemiphunga okwinqanaba lokuqala.
| Indlela yoNyango | Iimpawu eziphambili | Abaviwa abafanelekileyo | IiPros & Cons |
|---|---|---|---|
| Uqhaqho loTyando (VATS/Robotics) | Ukususwa ngokwasemzimbeni kwethumba kusetyenziswa iindlela ezincinci zokungena. | Izigulane ezine-Stage I-II NSCLC kunye nokusebenza kakuhle kwemiphunga. | IiPros: Ukunyangwa okunokwenzeka, ukususwa kwethumba kwangoko. Ububi: Imingcipheko yotyando, ixesha lokubuyisela, alifanelekanga abaviwa botyando abahluphekileyo. |
| Unyango ekujoliswe kulo | Amayeza omlomo ajolise kwiinguqu ezithile zofuzo (umzekelo, EGFR, ALK). | Izigulane ezinotshintsho lwabaqhubi oluchongiweyo; isetyenziswa rhoqo njenge-adjuvant okanye i-neoadjuvant. | IiPros: Ukusebenza okuphezulu, ukulawulwa komlomo, iziphumo ezibi ezimbalwa kune-chemo. Ububi: Uphuhliso lokumelana ngokuhamba kwexesha, lufuna uvavanyo lwemfuzo. |
| Immunotherapy | Iziyobisi ezandisa amajoni omzimba ukulwa nomhlaza. | Izigulane ezinenkcazo ephezulu ye-PD-L1 okanye njengenxalenye yonyango oludibeneyo. | IiPros: Iimpendulo ezihlala ixesha elide, ezinokubakho uxolelo lwexesha elide. Ububi: Iziganeko ezimbi ezinxulumene nomzimba, izinga lokuphendula eliguqukayo. |
| I-Antibody-Drug Conjugates (ADCs) | Ukuhanjiswa okujoliswe kuko kwee-agent ze-chemotherapy kwiiseli zomhlaza. | Izigulane ezine-resistant disease okanye i-antigen expression ethile (umzekelo, i-TROP2). | IiPros: Ukujolisa ngokuchanekileyo, okusebenzayo kwiimeko ezixhathisayo. Ububi: Iiprofayili ezithile zetyhefu (umzekelo, i-neutropenia), idatha ephumayo yexesha elide. |
Olu thelekiso lugxininisa ukubaluleka kweyeza lomntu. Alukho unyango “olungcono” lulodwa; ukhetho olufanelekileyo luxhomekeke kwiprofayili yebhayoloji yomntu kunye nesimo seklinikhi.
Nangona kukho inkqubela ebonakalayo, imingeni isahleli kumlo ochasene nomhlaza wemiphunga. Umahluko ekufikeleleni kwi unyango lomhlaza wemiphunga kwangoko phakathi kwemimandla yasezidolophini neyasemaphandleni, naphakathi kwamazwe ahlukeneyo, ngumqobo obalulekileyo.
Ngelixa i-AI inikezela ngesisombululo, ukusasazwa kwayo ngokubanzi kufuna iziseko zophuhliso kunye noqeqesho. Imimandla emininzi isaswele izixhobo zokubala okanye abasebenzi abanezakhono zokutolika iziphumo ze-AI ngokufanelekileyo. Iinzame ziyaqhubeka ukwenza ezi zixhobo zibe lula kwaye zidibanise nezixhobo eziphathwayo kwiindawo ezikude.
Amaphulo emfundo, afana nalawo aqaliswe nguMbutho wokuLwa noMhlaza waseTshayina, abalulekile. Bajonge ukwazisa uluntu ngokubaluleka kokuhlolwa kunye nokuphelisa iintsomi ezijikeleze ukuxilongwa komhlaza.
Ukungathinteleki kokunganyangeki ngamachiza kuhlala kuluchasi oloyikekayo. Abaphandi bahlala bephonononga iithagethi ezintsha kunye nezicwangciso ezidityanisiweyo zokuhlala phambi kokuvela kwe-tumor clones. Ugxininiso lutshintshela “kunyango oluguquguqukayo,” apho unyango luhlengahlengiswa ngokuguquguqukayo ngokusekwe kwixesha lokwenyani lokujonga impendulo yethumba.
Ukuqokelelwa kwedatha eninzi yeklinikhi kuqhuba igagasi elilandelayo lokufunyanwa. Ubungqina behlabathi lokwenyani (RWE) luncedisana nolingo olulawulwa ngokungenamkhethe ngokubonelela ngengqiqo malunga nendlela oluqhuba ngayo unyango kwiindawo ezahlukeneyo, zemihla ngemihla. Le datha iluncedo ekusulungekiseni izikhokelo kunye nokuphucula iinkqubo zonyango.
Ukunceda ngakumbi abafundi, nazi iimpendulo kwimibuzo eqhelekileyo malunga unyango lomhlaza wemiphunga kwangoko kwimeko yezonyango yangoku.
Ewe, umhlaza wemiphunga okwinqanaba lakwangoko (Inqanaba I kunye nele-II) unezinga eliphezulu lokunyangwa, ngakumbi xa unyangwa ngotyando olulandelwa lunyango olufanelekileyo lwe-adjuvant. Umyinge weminyaka emihlanu wokusinda kwiSigaba se-IA NSCLC unokudlula i-80-90% ngemigaqo yonyango yanamhlanje.
Kwiinkqubo zokulinga e-China, ukuhlolwa kwe-CT okuphuculweyo kwe-AI kunokubiza kancinci njenge-25 yeedola. Kwezinye iindawo zehlabathi, iindleko ziyahluka kakhulu ngokuxhomekeke kwinkqubo yokhathalelo lwempilo, i-inshurensi, kunye nobugcisa obuthile obusetyenziswayo. Ngokubanzi, ifikeleleka ngakumbi kunovavanyo lwemveli oluphindaphindiweyo ngenxa yokuchaneka okuphezulu.
Iziphumo ebezingalindelekanga ziyahluka ngokodidi lweziyobisi. Unyango olujoliswe kuyo luhlala lubangela ukuqhawuka kwesikhumba, urhudo, okanye ukuphakama kwe-enzyme yesibindi. I-Immunotherapies inokukhokelela kwiziganeko ezimbi ezinxulumene nomzimba ezichaphazela imiphunga, ikholoni, okanye i-endocrine glands. Ii-ADCs zinokubangela i-neutropenia okanye ukukhathala. Uninzi lweziphumo ebezingalindelekanga ziyalawuleka ngohlolo olululo lwezonyango.
Ewe, izibhedlele ezininzi ezikumgangatho ophezulu eTshayina, ezinjengezo zaseShanghai naseBeijing, zinamasebe aphesheya abonelela abaguli bangaphandle. Banikezela ngeenkonzo ezibanzi ezibandakanya uguqulelo, uncedo lwe-visa, kunye nezicwangciso zonyango ezilungiselelweyo. Ukusebenza kweendleko kunye nobuchwepheshe obuphambili benza i-China ibe yindawo ekhangayo yokhenketho lwezonyango kwi-oncology.
Unyaka ka-2026 uphawula umzuzu obalulekileyo kwimbali ye unyango lomhlaza wemiphunga kwangoko. Ukuhlangana kobukrelekrele bokwenziwa, amayeza achanekileyo, kunye neendlela ezintsha zonyango kuye kwajika into eyayikade isisigwebo sentambo yaba yimeko elawulekayo, nehlala inyangeka.
Ukusuka kwizibhedlele eziphithizelayo zaseShanghai ukuya kwiikliniki zoluntu ezixhotyiswe ngoxilongo lwe-AI, uluntu lwezonyango lwehlabathi lumanyene kwinjongo yalo yokufumanisa umhlaza wemiphunga kwangethuba kwaye luwunyange ngokufanelekileyo. Ukwehliswa okumangalisayo kweendleko zokuhlola kunye nokubakho konyango oluntsonkothileyo olufana nee-ADCs kunye nezilwa-buhlungu ezikhethekileyo zinika ithemba elitsha kwizigidi.
Kwizigulane kunye neentsapho, umyalezo ucacile: ukufunyanwa kwangoko kusindisa ubomi. Ukwamkela itekhnoloji entsha kunye nokubambelela kwizikhokelo zokuhlola awona manyathelo anamandla anokuthi awathathe. Njengoko uphando luqhubeka nokutyhala imida, ikamva lokhathalelo lomhlaza wemiphunga libonakala liqaqambile kunangaphambili, lithembisa ubomi obude kunye nomgangatho wobomi obungcono kubo bonke abachaphazelekayo.
Nokuba ucinga ngokhetho lokuhlola, uphonononga amaziko onyango, okanye ufuna unyango lwamva nje, izixhobo kunye nenkqubela phambili ekhoyo ngo-2026 ibonelela ngesiseko esomeleleyo sokulwa esi sifo. Hlala unolwazi, usebenze kwangoko, kwaye usebenzise amandla amayeza anamhlanje ukukhusela esona siphumo silungileyo.